Brief: Implanet granted ANVISA regulatory approval in Brazil to market the JAZZ Band platform
Nov 3 (Reuters) - Implanet SA IMPL.PA :
* Announces that it has received regulatory approval from
the Brazilian National Health Surveillance Agency (ANVISA) to
market its JAZZ Band platform
Source text for Eikon: ID:nBw8J4YFRa
Further company coverage: IMPL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Implanet SA
See all newsFrench orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth